Onsite OHS, Inc. develops, manufactures, and markets radiopharmaceuticals, medical devices, and imaging agents for the detection and treatment of oncological, cardiovascular, and neurological diseases. It offers radiopharmaceuticals, which are used in the field of nuclear medicine as tracers in the diagnosis and treatment of diseases. The company also provides medical devices, such as Gynocyte, a minimally invasive medical device that enables doctors to deliver treatment to patients with cervical and other gynecological cancers; and RubiGen, a mobile PET imaging system that consists of a rubidium generator, an infusion cart, and imaging accessories. In addition, it offers microbiological...